Search

Your search keyword '"Parissiadis A"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Parissiadis A" Remove constraint Author: "Parissiadis A"
190 results on '"Parissiadis A"'

Search Results

1. Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status

Catalog

Books, media, physical & digital resources

4. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

5. Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment

6. Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d’Histocompatibilité et d’Immunogénétique (SFHI)

8. Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment

13. Prospective Measures of Adherence by Questionnaire, Low Immunosuppression and Graft Outcome in Kidney Transplantation

16. Prospective Measures of Adherence by Questionnaire, Low Immunosuppression and Graft Outcome in Kidney Transplantation

17. Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort

18. Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus host disease in conjunction with the CMV status

19. Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status

20. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

27. Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation

28. HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation

29. Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort

35. Anti-donor HLA antibody response after pancreatic islet grafting: characteristics, risk factors and impact on graft function

36. Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation

37. Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)

38. Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation

39. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation

40. EPITOPE LOAD IS PREDECTIVE OF DE NOVO CLASS II DSA OCCURRENCE IN RENAL TRANSPLANT RECIPIENTS AFTER CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS

41. Survenue d’une thrombopénie sévère et durable, au décours d’une greffe de moelle allogénique, imputable à l’existence chez l’hôte d’une allo-immunisation anti-HPA-1

42. Identification de nouveaux allèles HLA en séquençage nouvelle génération HOLOTYPE OMIXON : retour d’expérience de 8 laboratoires EFS

43. Simultaneous Development of Lymphoma in Recipients of Renal Transplants from a Single Donor: Donor Origin Confirmed by Human Leukocyte Antigen Staining and Microsatellite Analysis

44. Matching for the non-conventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

45. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

46. Matching for the non-conventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

47. Identification de nouveaux allèles HLA en séquençage nouvelle génération HOLOTYPE OMIXON : retour d’expérience de 8 laboratoires EFS

48. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation

49. An intronic mutation responsible for a low level of expression of an HLA-A*24 allele

50. A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele